A Study of Enzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction Therapy
Clinical trial NCT04718779 · COMPLETED
Trial details
- NCT number
- NCT04718779
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2023-02-16
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.